IRIS
SILVESTRIS, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.276
NA - Nord America 2.155
EU - Europa 1.880
SA - Sud America 1.047
AF - Africa 94
OC - Oceania 3
Totale 7.455
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.075
SG - Singapore 1.098
BR - Brasile 903
IE - Irlanda 609
HK - Hong Kong 474
SE - Svezia 361
IT - Italia 353
CN - Cina 240
VN - Vietnam 187
DE - Germania 136
RU - Federazione Russa 72
FI - Finlandia 66
AT - Austria 63
AR - Argentina 60
IN - India 57
GB - Regno Unito 54
ID - Indonesia 52
MX - Messico 43
FR - Francia 41
BD - Bangladesh 31
NL - Olanda 30
IQ - Iraq 26
EC - Ecuador 25
ZA - Sudafrica 23
CA - Canada 20
UZ - Uzbekistan 20
PL - Polonia 18
MA - Marocco 16
TR - Turchia 16
ES - Italia 13
PK - Pakistan 13
VE - Venezuela 13
CO - Colombia 12
UA - Ucraina 12
EG - Egitto 11
JP - Giappone 11
CZ - Repubblica Ceca 10
PY - Paraguay 10
DZ - Algeria 9
TN - Tunisia 9
EE - Estonia 8
UY - Uruguay 8
CL - Cile 7
AE - Emirati Arabi Uniti 6
AL - Albania 5
IL - Israele 5
KE - Kenya 5
PE - Perù 5
SC - Seychelles 5
BO - Bolivia 4
CI - Costa d'Avorio 4
ET - Etiopia 4
JM - Giamaica 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BZ - Belize 3
CR - Costa Rica 3
IR - Iran 3
JO - Giordania 3
KG - Kirghizistan 3
LT - Lituania 3
LV - Lettonia 3
OM - Oman 3
SA - Arabia Saudita 3
SN - Senegal 3
AO - Angola 2
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
BY - Bielorussia 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
IS - Islanda 2
LK - Sri Lanka 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
TH - Thailandia 2
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
Totale 7.449
Salva come PNG Salva come JPEG
Città #
Dublin 609
Hong Kong 472
Singapore 364
Ashburn 354
Nyköping 349
Princeton 268
Dallas 242
Messina 155
Medford 107
Beijing 91
Chandler 86
Los Angeles 83
São Paulo 71
Ho Chi Minh City 64
Nuremberg 59
Redondo Beach 43
New York 41
Hanoi 39
Jakarta 39
Vienna 37
Buffalo 33
Rio de Janeiro 30
Pune 29
Munich 26
Lappeenranta 25
Milan 24
Moscow 22
The Dalles 21
Turku 20
Helsinki 19
Tashkent 19
Frankfurt am Main 18
Arezzo 16
Brasília 16
Brooklyn 16
Porto Alegre 15
Amsterdam 14
Rome 14
Campinas 13
Mexico City 13
Belo Horizonte 12
Denver 12
Johannesburg 12
London 12
Tianjin 12
Zhengzhou 12
Catania 11
Düsseldorf 11
Paternò 11
Quito 11
Stockholm 11
Baghdad 10
Biên Hòa 10
Boston 10
Haiphong 10
Orem 10
Rheinfelden 10
Salvador 10
Santa Clara 10
Sorocaba 10
Tokyo 10
Warsaw 10
Portsmouth 9
Atlanta 8
Bari 8
Brno 8
Chennai 8
Curitiba 8
Guayaquil 8
Maceió 8
Montreal 8
Pittsburgh 8
Poplar 8
Prineville 8
Bexley 7
Cairo 7
Chicago 7
Cuiabá 7
Lauterbourg 7
Montevideo 7
Phoenix 7
Ribeirão Preto 7
Seattle 7
Contagem 6
Dhaka 6
Fort Worth 6
Fortaleza 6
Hải Dương 6
Juiz de Fora 6
Manaus 6
Santo André 6
Springfield 6
São Gonçalo 6
Uberaba 6
Ankara 5
Bogotá 5
Cape Town 5
Charlotte 5
Guarulhos 5
Istanbul 5
Totale 4.469
Salva come PNG Salva come JPEG
Nome #
Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype. 160
A moonshot approach toward the management of cancer patients in the COVID-19 time: What have we learned and what could the Italian network of cancer centers (Alliance against Cancer, ACC) do after the pandemic wave? 90
Actors on the Scene: Immune Cells in the Myeloma Niche 89
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 87
Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review 84
Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors 84
Autophagic-Related Proteins in Brain Gliomas: Role, Mechanisms, and Targeting Agents 82
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial 82
Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do 79
Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines 79
A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized Medicine 78
Rare histotypes of epithelial biliary tract tumors: A literature review 71
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 70
Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario 69
Immune checkpoint inhibitors and neurotoxicity: a focus on diagnosis and management for a multidisciplinary approach 68
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 66
Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path? 66
Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection 66
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database 63
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study 62
Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System 61
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 59
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules 59
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System 58
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 58
[Apoptosis or programmed cell death: regulatory and pathophysiological mechanisms]. FT Apoptosi, o morte cellulare programmata: meccanismi regolatori e fisiopatologia 58
Dihydropyrimidine Dehydrogenase Polymorphism c.2194G>A Screening Is a Useful Tool for Decreasing Gastrointestinal and Hematological Adverse Drug Reaction Risk in Fluoropyrimidine-Treated Patients 57
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 57
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine 56
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals 56
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 56
Comparison Study of the Safety Profile of Olaparib Versus Niraparib: Analysis of Real-World Data from EudraVigilance 55
A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers 55
Laparoscopic vs. open mesorectal excision for rectal cancer: Are these approaches still comparable? A systematic review and meta-analysis 54
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial 54
Active treatment given in the last weeks of life: poor quality cancer care or justifiable behavior? 54
Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics Study 54
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy 53
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 53
[Paraneoplastic syndromes of the central nervous system] 53
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis 53
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 53
STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients 53
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 51
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF Italian Scientific Societies 51
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell’Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO) 51
Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer 51
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 51
Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: Evidence evaluation and recommendations by the italian association of medical oncology (AIOM) 51
From bench to bedside: highlights from the International Dialogue on Ovarian Cancer 50
Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes 50
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 50
Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial 50
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery 50
Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review 49
Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database 49
A Systematic Review of the Tumor-Infiltrating CD8+ T-Cells/PD-L1 Axis in High-Grade Glial Tumors: Toward Personalized Immuno-Oncology 49
Biomarker phenotyping drives clinical management in axillary sentinel node: A retrospective study on women with primary breast cancer in 2002 49
Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study 48
Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM) 47
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib 47
[Indices of disease activity in systemic lupus erythematosus. Review of the literature] 47
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials 47
Prediction and validation of GUCA2B as the hub-gene in colorectal cancer based on co-expression network analysis: In-silico and in-vivo study 47
PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines 46
The latest findings of PD-1/PD-L1 inhibitor application in gynecologic cancers 46
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer 45
A Promising Role of TGF-β Pathway in Response to Regorafenib in Metastatic Colorectal Cancer: A Case Report 45
Exploiting systems biology to investigate the gene modules and drugs in ovarian cancer: A hypothesis based on the weighted gene co-expression network analysis 44
Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 44
Current approaches for combination therapy of cancer: The role of immunogenic cell death 44
Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: Promising combination treatment against triple-negative breast cancer? 43
A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead 43
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 43
Rapid serological and SARS-CoV-2 RT-PCR assays: comparison performed simultaneously in symptomatic COVID-19 patients 42
A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer 42
Microfluidic-Assisted Preparation of Targeted pH-Responsive Polymeric Micelles Improves Gemcitabine Effectiveness in PDAC: In Vitro Insights 41
Varied functions of immune checkpoints during cancer metastasis 41
Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study 41
[Common variable immunodeficiency]. FT Immunodeficienza comune variabile 41
mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail Patients 40
Challenges and pitfalls in the management of endocrine toxicities from immune checkpoint inhibitors: a case presentation of synchronous thyrotoxicosis and primary adrenal insufficiency in a melanoma patient 40
NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer 40
MiR-144: A new possible therapeutic target and diagnostic/prognostic tool in cancers 40
Identification of early diagnostic biomarkers via WGCNA in gastric cancer 40
A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study 39
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples 38
The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy 37
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System 37
The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer 37
On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents 37
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world 36
COVID-19 pandemic and the crisis of health systems: The experience of the apulia cancer network and of the comprehensive cancer center Istituto tumori “Giovanni Paolo II” of Bari 35
Immunotherapy of cancer in single-cell RNA sequencing era: A precision medicine perspective 35
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment 35
Vaccination for seasonal influenza in patients with cancer: Recommendations of the Italian Society of Medical Oncology (AIOM) 34
Angiogenesis in adenosquamous cancer of pancreas 34
COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients? 34
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology 33
Is it Time for a Therapeutic Algorithm in Resected Pancreatic Ductal Adenocarcinoma? 33
Totale 5.334
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.258
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022388 0 0 0 0 0 0 0 0 8 0 0 380
2022/20231.548 307 183 131 7 28 93 32 45 663 9 13 37
2023/2024379 53 58 33 27 33 55 44 10 9 8 6 43
2024/20252.786 66 43 46 127 209 84 126 389 564 233 301 598
2025/20262.529 358 470 572 503 568 58 0 0 0 0 0 0
Totale 7.630